[26PS3-pm] Pharmacotherapies (Cancer) 3

Sun. Mar 26, 2023 5:00 PM - 6:24 PM [Room PS3] (2F)

Chair: Hiroto Hatakeyama, Masanori Tachikawa

+Add all to schedule

5:00 PM - 5:12 PM

[26PS3-pm14S] Ezrin contributes to the plasma membrane expression of Programmed Death Ligand-1 in A2780 cells

○Honami Ishikawa¹, Mayuka Tameishi¹, Chihiro Tanaka¹, Takuro Kobori¹, Yoko Urashima¹, Takuya Ito¹, Tokio Obata¹ (1. Osaka Ohtani Univ.)

5:12 PM - 5:24 PM

[26PS3-pm15S] Suppression of histone deacetylases reduces ABCG2 expression and number of side population cells

○Shunji Haruna¹, Yu Kato¹, Tomoki Arimura¹, Yuka Kadoishi¹, Haruka Kamiyama¹, Shingo Kondo¹, Yoshikazu Sugimoto¹ (1. Facul. Pharm., Keio Univ.)

5:24 PM - 5:36 PM

[26PS3-pm16S] Novel drug therapy targeting NF-kB signal for triple-negative breast cancer patients with loss of CYLD expression

○Hitomi Arakaki¹, Akari Kuwano¹, Chika Hirai¹, Chica Saigo², Ayumi Kanemaru¹, Mitsuhiro Hayashi³, Hideyuki Saito^1,2, Yuki Narita^1,2, Hirofumi Jono^1,2 (1. Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University., 2. Department of Pharmacy, Kumamoto University Hospital., 3. Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University.)

5:36 PM - 5:48 PM

[26PS3-pm17S] Effect of acquired cisplatin resistance on cytotoxicity of 5-aminolevulinic acid-mediated photodynamic therapy on human lung cancer cell line A549

○Risa Fuse¹, Sayo Horibe¹, Haruka Ikezawa¹, Yuka Higashira¹, Toru Tanaka¹, Shoji Kawauchi¹, Naoto Sasaki¹, Yoshiyuki Rikitake¹ (1. Kobe Pharmaceutical Univ.)

5:48 PM - 6:00 PM

[26PS3-pm18S] Induction of ferroptosis as a novel therapeutic strategy for malignant mesothelioma

○Yumi Matsui¹, Tatsuhiro Sato², Taichi Ohshiro³, Tohru Maeda¹, Yoshitaka Sekido² (1. Dept. Pharm., Kinjo Gakuin Univ. , 2. Div. Cancer Biol., Aichi Cancer Cent., 3. Grad. Sch. Pharm. Sci., Kitasato Univ.)

6:00 PM - 6:12 PM

[26PS3-pm19] Development of effective cancer therapy by nanomedicine delivery based on the enhancement of vascular permeability in tumor tissue using microbubbles and ultrasound exposure

○Saori Kageyama¹, Daiki Omata¹, Lisa Munakata¹, Tadamitsu Shima¹, Yuno Suzuki¹, Ryo Suzuki^1,2, Kazuo Maruyama^1,2 (1. Pharm. Sci., Teikyo Univ., 2. ACRO, Teikyo Univ.)

6:12 PM - 6:24 PM

[26PS3-pm20S] Study on Tolerability of Enzalutamide in Castration-resistant Prostate Cancer

○Chihiro Iwai¹, Ayaka Sakai¹, Haruka Sahashi¹, Emiri Matsumiya¹, Katsura Tsukamoto¹, Midori Soda¹, Akiyo Hori², Takashi Mizui², Hisao Komeda³, Kiyoyuki Kitaichi¹ (1. Gifu Pharm Univ, 2. Dept of Pharmacy, Gifu Muncpl Hosp, 3. Dept of Urology, Gifu Muncpl Hosp)

Session information